Vascular endothelial growth factor augments human herpesvirus-8 (HHV-8/KSHV) infection
- PMID: 15254407
- DOI: 10.4161/cbt.3.9.1054
Vascular endothelial growth factor augments human herpesvirus-8 (HHV-8/KSHV) infection
Abstract
Human herpesvirus-8 (HHV-8/KSHV) is etiologically associated with Kaposi's sarcoma (KS) and other tumors. The Raf oncoprotein enhances HHV-8 infection of target cells. In addition, we have previously demonstrated that Raf induces vascular endothelial growth factor (VEGF) expression. VEGF is a growth factor that has autocrine growth activity and has been implicated in the formation of the spindle shape cell morphology characteristic of Kaposi's sarcoma (KS). The aim of this study was to test the hypothesis that VEGF enhances infection of HHV-8. Herein, we demonstrate that the soluble VEGF enhanced green florescence protein encoding (GFP)-HHV-8 (rKSHV.152) infection of human foreskin fibroblasts (HFF) and not of 293 cells. We found this to be in part, due to the fact that HFF inherently produces significantly lower concentrations of VEGF when compared to 293 cells. Treating 293 cells (but not HFF) with a VEGF receptor (VEGFR) inhibitor significantly lowered infection. Furthermore, transfecting 293 cells with VEGF specific si-RNA did not alter the binding of HHV-8 to cells; but significantly lowered VEGF expression and thus GFP-HHV-8 infection. Interestingly, lowering VEGF expression in 293 cells wtih VEGF specific si-RNA did not completely inhibit GFP-HHV-8 infection. We conclude that VEGF is not a requirement for HHV-8 infection; but VEGF plays a major role in augmenting infection at a post binding stage of entry. These findings suggest that targeting VEGF/VEGFR may prove efficacious in controlling HHV-8 associated pathogenesis.
Similar articles
-
Raf-induced vascular endothelial growth factor augments Kaposi's sarcoma-associated herpesvirus infection.J Virol. 2004 Dec;78(23):13381-90. doi: 10.1128/JVI.78.23.13381-13390.2004. J Virol. 2004. PMID: 15542692 Free PMC article.
-
Raf promotes human herpesvirus-8 (HHV-8/KSHV) infection.Oncogene. 2004 Jul 1;23(30):5227-41. doi: 10.1038/sj.onc.1207643. Oncogene. 2004. PMID: 15122343
-
Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection.Cancer Res. 2004 Jan 1;64(1):72-84. doi: 10.1158/0008-5472.can-03-2767. Cancer Res. 2004. PMID: 14729610
-
Raf and VEGF: emerging therapeutic targets in Kaposi's sarcoma-associated herpesvirus infection and angiogenesis in hematopoietic and nonhematopoietic tumors.Leukemia. 2005 Jan;19(1):18-26. doi: 10.1038/sj.leu.2403532. Leukemia. 2005. PMID: 15470486 Review.
-
[Human herpesvirus 8].Ann Med Interne (Paris). 1997;148(5):385-9. Ann Med Interne (Paris). 1997. PMID: 9538414 Review. French.
Cited by
-
CIB1 synergizes with EphrinA2 to regulate Kaposi's sarcoma-associated herpesvirus macropinocytic entry in human microvascular dermal endothelial cells.PLoS Pathog. 2014 Feb 13;10(2):e1003941. doi: 10.1371/journal.ppat.1003941. eCollection 2014 Feb. PLoS Pathog. 2014. PMID: 24550731 Free PMC article.
-
Differential regulation of the attachment of Kaposi's sarcoma-associated herpesvirus (KSHV)-infected human B cells to extracellular matrix by KSHV-encoded gB and cellular alphaV integrins.Cell Microbiol. 2008 Jul;10(7):1546-58. doi: 10.1111/j.1462-5822.2008.01149.x. Epub 2008 Mar 25. Cell Microbiol. 2008. PMID: 18363908 Free PMC article.
-
Cell membrane-bound Kaposi's sarcoma-associated herpesvirus-encoded glycoprotein B promotes virus latency by regulating expression of cellular Egr-1.J Biol Chem. 2010 Nov 26;285(48):37491-502. doi: 10.1074/jbc.M110.159103. Epub 2010 Sep 23. J Biol Chem. 2010. PMID: 20864524 Free PMC article.
-
Evidence for altered host genetic factors in KSHV infection and KSHV-related disease development.Rev Med Virol. 2021 Mar;31(2):e2160. doi: 10.1002/rmv.2160. Epub 2020 Oct 11. Rev Med Virol. 2021. PMID: 33043529 Free PMC article. Review.
-
Effects of inhalant nitrites on VEGF expression: a feasible link to Kaposi's sarcoma?J Neuroimmune Pharmacol. 2006 Sep;1(3):317-22. doi: 10.1007/s11481-006-9024-4. J Neuroimmune Pharmacol. 2006. PMID: 18040808 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous